IRIS
VALENTINI, Gabriele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 11.254
NA - Nord America 5.285
AS - Asia 619
Continente sconosciuto - Info sul continente non disponibili 14
SA - Sud America 14
AF - Africa 1
OC - Oceania 1
Totale 17.188
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 5.592
US - Stati Uniti d'America 5.211
IE - Irlanda 1.842
UA - Ucraina 1.115
GB - Regno Unito 773
FR - Francia 535
DE - Germania 489
CN - Cina 360
FI - Finlandia 274
SE - Svezia 249
GR - Grecia 192
TR - Turchia 190
CA - Canada 73
BE - Belgio 68
IN - India 26
ES - Italia 21
PL - Polonia 20
CH - Svizzera 15
NL - Olanda 14
EU - Europa 12
BR - Brasile 9
RO - Romania 9
CZ - Repubblica Ceca 8
RU - Federazione Russa 8
TW - Taiwan 8
HR - Croazia 7
ID - Indonesia 7
SG - Singapore 7
AT - Austria 6
HU - Ungheria 5
JP - Giappone 5
BY - Bielorussia 3
EC - Ecuador 3
AP - ???statistics.table.value.countryCode.AP??? 2
DK - Danimarca 2
HK - Hong Kong 2
IQ - Iraq 2
IR - Iran 2
KR - Corea 2
MK - Macedonia 2
AU - Australia 1
BD - Bangladesh 1
BG - Bulgaria 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
MY - Malesia 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SM - San Marino 1
TH - Thailandia 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 17.188
Salva come PNG Salva come JPEG
Città #
Dublin 1.836
Jacksonville 1.574
Chandler 756
Rome 319
Princeton 287
Medford 254
Milan 250
Ann Arbor 166
Napoli 156
San Mateo 152
Roxbury 147
Boardman 144
Beijing 143
Wilmington 137
Woodbridge 113
Bremen 112
Naples 86
Cambridge 81
Des Moines 64
Mountain View 64
Brussels 62
Florence 62
Turin 61
Caserta 53
Palermo 53
Ottawa 51
Nanjing 48
Catania 43
Bari 41
Ashburn 40
New York 38
Bologna 33
Torino 27
Verona 25
Mcallen 23
Helsinki 22
Padova 22
Genoa 21
Houston 21
Pescara 21
Redwood City 21
Jinan 19
Dallas 18
Genova 18
Cagliari 17
Düsseldorf 17
Kunming 17
Messina 17
Norwalk 17
Vicenza 16
Gorno 15
Auburn Hills 14
Salerno 14
Trieste 14
Falls Church 13
Hebei 13
Parma 13
Brescia 12
Montréal 12
Perugia 12
Reggio Calabria 12
Taranto 12
Venice 12
Belluno 11
Livorno 11
Nanchang 11
Ningbo 11
Torre del Greco 11
Trento 11
Varese 11
Fiano Romano 10
Guangzhou 10
Lanzhou 10
Mykolayiv 10
Bastia umbra 9
Bergamo 9
Cosenza 9
Hanover 9
Lucca 9
Marano Di Napoli 9
Rimini 9
Terni 9
Assisi 8
Brno 8
Carbonera 8
Hefei 8
Latina 8
Los Angeles 8
Monza 8
Pavia 8
Prato 8
Reggio Emilia 8
Sacramento 8
Seattle 8
Aversa 7
Bolzano 7
Catanzaro 7
Changsha 7
Dearborn 7
Forlì 7
Totale 8.280
Salva come PNG Salva come JPEG
Nome #
ARTRITE PSORIASICA ED INTERSTIZIOPATIA POLMONARE : DESCRIZIONE DI UN CASO CLINICO. 5.647
ANTI TNF ALFA IN PAZIENTI AFFETTI DA ARTRITE REUMATOIDE E SPONDILOARTRITI HBV CARRIERS OCCULTI:STUDIO RETROSPETTIVO SULLA SICUREZZA 194
A PILOT STUDY ON LOW-DOSE INTRAVENOUS CICLOPHOSPHAMIDE IN SYSTEMIC SCLEROSIS: EFFICACY, SAFETY AND EFFECTS ON CELLULAR ACTIVATION MARKERS 100
Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in systemic sclerosis 90
ANTI-TNFα TREATMENT IS ASSOCIATED WITH INCREASED LIVER STIFFNESS IN HBV OCCULT CARRIER PATIENTS 84
Polymorphism of immunoglobulin enhancer element HS1,2A: allele *2 associates with systemic sclerosis. Comparison with HLA-DR and DQ allele frequency 77
Antinuclear antibodies in first-degree relatives of patients with polymyositis-dermatomyositis: analysis of the relationship with HLA haplotypes 77
Early Systemic Sclerosis: Marker Autoantibody Positive Patients Have A Faster Pace Of The Disease. 77
Early systemic sclerosis: Analysis of the disease course in patients with marker autoantibody or capillaroscopic positivity or both. 73
Peripheral blood T lymphocytes from systemic sclerosis patients show both Th1 and Th2 activation 73
Clinical correlates of human leukocyte antigen-G (HLA-G) in systemic sclerosis. 73
Clinical and subclinical atherosclerosis in systemic sclerosis: consequences of previous corticosteroid treatment. 73
[HAQ-DI Italian version in systemic sclerosis]. 71
EUSTAR biobanking: recommendations for the collection, storage and distribution of biospecimens in scleroderma research 65
-238 and +489 TNF-alpha along with TNF-RII gene polymorphisms associate with the diffuse phenotype in patients with Systemic Sclerosis 62
.ANTI-TNF alfa IN PATIENTS WITH EITHER RHEUMATOID ARTHRITIS OR SPONYLOATHRITIS And CONCURRENT C HEPATITIS:A RETROSPECTIVE RECORD REVIEW ON SAFETY 62
Alterazioni del sistema nervoso autonomo nella Sclerosi Sistemica (SSc). Risultati preliminari di uno studio sul rapporto con la severita della malattia 61
[T-lymphocyte subpopulations in the conjunctiva of subjects with secondary Sjogren's syndrome] 61
CXCL4 in undifferentiated connective tissue disease at risk for systemic sclerosis (SSc) (previously referred to as very early SSc) 61
Evaluation of cardiac structures and function in systemic sclerosis by Doppler echocardiography 60
Sub-Analysis of ELF Score Biomarkers Components Indicates a Specific Correlation with Different Organ Involvement in Systemic Sclerosis. 60
Association of a functional polymorphism in the matrix metalloproteinase-12 promoter region with systemic sclerosis in an Italian population 59
Adult-onset Still's disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 59
Anti-centromere protein A antibodies in systemic sclerosis: Significance and origin 59
Prevalence of anti-toxoplasma antibodies in patients with autoimmune diseases. 58
Tissue Doppler imaging in systemic sclerosis: A 3-year longitudinal study. 58
Early systemic sclerosis: marker autoantibodies and videocapillaroscopy patterns are each associated with distinct clinical, functional and cellular activation markers. 58
[Comparison between auranofin and chloroquine in the therapy of rheumatoid arthritis] 58
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: data from the Campania Rare Disease Registry 58
Cardiac involvement in rheumatoid arthritis: an echocardiographic study 57
ELF Score: A Validated Serum Test Strongly Predictive of Fibrosis in Systemic Sclerosis. 56
Glucocorticoids in systemic sclerosis: weighing the benefits and risks - a systematic review 55
Low-dose intravenous cyclophosphamide in systemic sclerosis: an open prospective efficacy study in patients with early diffuse disease 55
Assessment of intestinal permeability and orocecal transit time in patients with systemic sclerosis 55
Systemic sclerosis could mask the presentation of psoriasis in a patient with symptomatic and bilateral sacroiliitis 55
Crioglobulinemia mista essenziale: prevalenza e caratteri della neuropatia periferica 55
RELATIONSHIP OF THE 6-MIN WALKING TEST AND QUALITY OF LIFE 55
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database 54
Effects and safety of rituximab in systemic sclerosis: An analysis from the European Scleroderma Trial and Research (EUSTAR) group 54
Succesfull neridronate therapy in transient osteoporosis of the hip 54
Morphea developing in patients previously affected with eosinophilic fasciitis. Report of two cases 54
ARTHRITIS IS ASSOCIATED WITH PSORIASIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES 54
Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus 54
Cell-free DNA in the plasma of patients with systemic sclerosis 53
High IL-17E and Low IL-17C Dermal Expression Identifies a Fibrosis-Specific Motif Common to Morphea and Systemic Sclerosis. 53
Impaired exercise performance in systemic sclerosis and its clinical correlations 53
Alterazione del riempimento ventricolare sinistro nella sclerosi sistemica (SSc): risultati di uno studio Iongitudinale 53
Early systemic sclerosis: assessment of clinical and pre-clinical organ involvement in patients with different disease features 53
ATHEROSCLEROSIS AND RHEUMATOID ARTHRITIS: EVALUATION OF INTIMA-MEDIA THICKNESS AND CORRELATION WITH INFLAMMATORY AND ATHEROGENIC MARKERS 53
Prevalence and factors associated with glucocorticoids (GC) use in systemic sclerosis (SSc): a systematic review and meta-analysis of cohort studies and registries 52
Peripheral T lymphocytes from patients with early systemic sclerosis co-cultured with autologous fibroblasts undergo an oligoclonal expansion similar to that occurring in the skin 52
Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients 52
Association of the CD226 Ser(307) variant with systemic sclerosis: evidence of a contribution of costimulation pathways in systemic sclerosis pathogenesis 52
Diastolic abnormalities in systemic sclerosis: evidence for associated defective cardiac functional reserve 52
Low-dose pulse cyclophosphamide in interstitial lung disease associated with systemic sclerosis (SSc-ILD): Efficacy of maintenance immunosuppression in responders and non-responders. 52
Adult-onset Still's disease: Evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 52
Glucocorticoids in systemic sclerosis: patients' beliefs and treatment adherence. 51
[Italian consensus on the recommendations about the use of methotrexate for the treatment of rheumatic diseases with a focus on rheumatoid arthritis: results from the "3E initiative"]. 51
[A comparison between the Simplified Disease Activity Index (SDAI) and the Disease Activity Score (DAS28) as measure of response to treatment in patients undergoing different therapeutic regimens]. 51
PREVALENCE OF ANTIBODIES RECOGNAIZING CYCLIC CITRULLINATED PEPTIDE(anti CCP) IN PATIENTS WITH ULCERATIVE COLITIS 51
RELAPSING POLYCHONDRITIS. AN HYSTOCHEMICAL STUDY BY LECTIN. 51
Increased expression of CD40 ligand in activated CD4+ T lymphocytes of systemic sclerosis patients 51
Serological and clinical markers of autoimmune disease in HCV-infected subjects with different disease conditions 51
[Survival and death causes in 251 systemic sclerosis patients from a single Italian center]. 51
Right atrial morphology and function in patients with systemic sclerosis compared to healthy controls: a two-dimensional strain study 51
ANTI-TOPOISOMERASE I (ANTI-SCL-70) AND CANCER IN SYSTEMIC SCLEROSIS. ARE THEY RELATED? 51
Evidence for peripheral impaired glucose handling in patients with connective tissue diseases 50
The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis. 50
EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR) 50
Early Systemic Sclerosis: Serum Profiling of Factors Involved in Endothelial, T-cell, and Fibroblast Interplay is Marked by Elevated Interleukin-33 Levels. 50
The incidence of cardiovascular events in Italian patients with systemic lupus erythematosus is lower than in North European and American cohorts: Implication of disease-associated and traditional risk factors as emerged by a 16-year retrospective GIRRCS study 50
New strategies to address the pharmacodynamics and pharmacokinetics of tumor necrosis factor (TNF) inhibitors: A systematic analysis. 49
Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative 49
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group 49
Factors influencing pain, physical function and social functioning in patients with osteoarthritis in southern Italy. 49
Twelve-month azathioprine as maintenance therapy in early diffuse systemic sclerosis patients treated for 1-year with low dose cyclophosphamide pulse therapy 49
Quality of life as measured by the short-form 36 (SF-36) questionnaire in patients with early systemic sclerosis and undifferentiated connective tissue disease. 49
Thrombocytosis in progressive generalized sclerosis (scleroderma) and in other rheumatic diseases 49
Anti-inflammatory: new trends in the treatment of the patient with systemic sclerosis 49
Brief report: Successful pregnancies but a higher risk of preterm births in systemic sclerosis: An Italian multicentric study. 49
VALIDATION OF THE SIMPLIFIED DISEASE ACTIVITY INDEX (SDAI) AND DAS28 AS MEASURE OF RESPONSE TO TREATMENT IN PATIENTS UNDERGOING DIFFERENT THERAPEUTIC REGIMENS 49
Aggressive rheumatoid arthritis registry in Italy. Characteristics of the early rheumatoid arthritis subtype among patients classified according to the ACR criteria 49
The use of monoclonal antibody against alpha-1 antitripsin in diagnostic screening of inflammatory disorders 48
Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis 48
The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy 48
Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study 48
[Copernican revolution in the therapy of rheumatoid arthritis: the contribution of anti-TNFalpha drugs]. 48
[Absolute and relative increase in Leu-11b+ cells in patients with systemic scleroderma] 48
Low-dose aspirin as primary prophylaxis for cardiovascular events in systemic lupus erythematosus: A long-term retrospective cohort study 48
The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: Derivation and validation of a preliminarily revised EUSTAR activity index 48
ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis-a EUSTAR analysis. 48
Scleroderma renal crisis analysis of prevalence and outcome in a large italian series. 47
Correlations of Y chromosome microchimerism with disease activity in patients with SLE: analysis of preliminary data 47
The assessment of the patient with systemic sclerosis. Introduction 47
European Scleroderma Study Group (ESCSG) Activity Index is correlated to quality of life measures both at admission and overtime 47
Cardiac involvement in undifferentiated connective tissue disease at risk for systemic sclerosis (otherwise referred to as very early-early systemic sclerosis): a TDI study 47
Association of a KCNA5 gene polymorphism with systemic sclerosis-associated pulmonary arterial hypertension in the European Caucasian population 46
Studio neurofisiologico in 17 casi di crioglobulinemia. Rivista Italiana di EEG e Neurofisiologia Clinica : , 46
Pregnancy and systemic sclerosis 46
Development of a provisional core set of response measures for clinical trials of systemic sclerosis 46
Totale 11.267
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.571
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.571
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019176 0 0 0 0 0 0 0 0 0 51 58 67
2019/20202.466 367 341 119 61 303 102 422 181 251 127 106 86
2020/20213.084 282 76 331 164 466 111 381 316 137 362 311 147
2021/20222.629 245 77 93 103 736 103 106 161 134 120 201 550
2022/20234.521 429 195 113 303 393 316 112 297 1.763 184 204 212
2023/20242.181 195 131 182 285 626 109 189 230 130 104 0 0
Totale 17.774